The European Medicines Agency (EMA) recently reported that one of the manufacturers of the active ingredient Valsartan, Zhejing Huahai Pharmaceutical Co. Ltd. Channan Site, RC-317016, China, identified the presence of an impurity in the batches manufactured and marketed to various pharmaceutical companies worldwide.

For more information go to http://www.msp.gub.uy/noticia/retiro-preventivo-de-medicamentos-conteniendo-valsartan